Medical Devices & Consumables
Global Molecular Diagnostics for Infectious Diseases Market Research Report 2025
- Sep 24, 25
- ID: 523088
- Pages: 108
- Figures: 108
- Views: 7
Report Scope
This report aims to provide a comprehensive presentation of the global market for Molecular Diagnostics for Infectious Diseases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Diagnostics for Infectious Diseases.
The Molecular Diagnostics for Infectious Diseases market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Molecular Diagnostics for Infectious Diseases market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Molecular Diagnostics for Infectious Diseases manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Roche Diagnostics
Illumina
Qiagen
Abbott Laboratories
BioMérieux
Cepheid (Danaher)
Thermo Fisher Scientific
Hologic
DiaSorin
Luminex
Hoffmann-La Roche
Biocartis
Nanomix
BioFire Diagnostics
Seegene
QuidelOrtho
ZeptoMetrix
Sansure
BGI Genomics
DaAn Gene
Kehua Bio-engineering
Segment by Type
Respiratory Tract Infections
Reproductive Tract Infections
Blood-borne Infections (BBIs)
Gastrointestinal Infections (GIIs)
Other Infections
Segment by Application
Hospital
Diagnostic Laboratories
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Molecular Diagnostics for Infectious Diseases manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Molecular Diagnostics for Infectious Diseases in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for Molecular Diagnostics for Infectious Diseases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Diagnostics for Infectious Diseases.
The Molecular Diagnostics for Infectious Diseases market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Molecular Diagnostics for Infectious Diseases market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Molecular Diagnostics for Infectious Diseases manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Roche Diagnostics
Illumina
Qiagen
Abbott Laboratories
BioMérieux
Cepheid (Danaher)
Thermo Fisher Scientific
Hologic
DiaSorin
Luminex
Hoffmann-La Roche
Biocartis
Nanomix
BioFire Diagnostics
Seegene
QuidelOrtho
ZeptoMetrix
Sansure
BGI Genomics
DaAn Gene
Kehua Bio-engineering
Segment by Type
Respiratory Tract Infections
Reproductive Tract Infections
Blood-borne Infections (BBIs)
Gastrointestinal Infections (GIIs)
Other Infections
Segment by Application
Hospital
Diagnostic Laboratories
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Molecular Diagnostics for Infectious Diseases manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Molecular Diagnostics for Infectious Diseases in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Molecular Diagnostics for Infectious Diseases Market Overview
1.1 Product Definition
1.2 Molecular Diagnostics for Infectious Diseases by Type
1.2.1 Global Molecular Diagnostics for Infectious Diseases Market Value Comparison by Type (2024 VS 2031)
1.2.2 Respiratory Tract Infections
1.2.3 Reproductive Tract Infections
1.2.4 Blood-borne Infections (BBIs)
1.2.5 Gastrointestinal Infections (GIIs)
1.2.6 Other Infections
1.3 Molecular Diagnostics for Infectious Diseases by Application
1.3.1 Global Molecular Diagnostics for Infectious Diseases Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Diagnostic Laboratories
1.4 Global Molecular Diagnostics for Infectious Diseases Market Size Estimates and Forecasts
1.4.1 Global Molecular Diagnostics for Infectious Diseases Revenue 2020-2031
1.4.2 Global Molecular Diagnostics for Infectious Diseases Sales 2020-2031
1.4.3 Global Molecular Diagnostics for Infectious Diseases Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Molecular Diagnostics for Infectious Diseases Market Competition by Manufacturers
2.1 Global Molecular Diagnostics for Infectious Diseases Sales Market Share by Manufacturers (2020-2025)
2.2 Global Molecular Diagnostics for Infectious Diseases Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Molecular Diagnostics for Infectious Diseases Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Molecular Diagnostics for Infectious Diseases, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Molecular Diagnostics for Infectious Diseases, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Molecular Diagnostics for Infectious Diseases, Product Type & Application
2.7 Global Key Manufacturers of Molecular Diagnostics for Infectious Diseases, Date of Enter into This Industry
2.8 Global Molecular Diagnostics for Infectious Diseases Market Competitive Situation and Trends
2.8.1 Global Molecular Diagnostics for Infectious Diseases Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Molecular Diagnostics for Infectious Diseases Players Market Share by Revenue
2.8.3 Global Molecular Diagnostics for Infectious Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Molecular Diagnostics for Infectious Diseases Market Scenario by Region
3.1 Global Molecular Diagnostics for Infectious Diseases Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Molecular Diagnostics for Infectious Diseases Sales by Region: 2020-2031
3.2.1 Global Molecular Diagnostics for Infectious Diseases Sales by Region: 2020-2025
3.2.2 Global Molecular Diagnostics for Infectious Diseases Sales by Region: 2026-2031
3.3 Global Molecular Diagnostics for Infectious Diseases Revenue by Region: 2020-2031
3.3.1 Global Molecular Diagnostics for Infectious Diseases Revenue by Region: 2020-2025
3.3.2 Global Molecular Diagnostics for Infectious Diseases Revenue by Region: 2026-2031
3.4 North America Molecular Diagnostics for Infectious Diseases Market Facts & Figures by Country
3.4.1 North America Molecular Diagnostics for Infectious Diseases Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Molecular Diagnostics for Infectious Diseases Sales by Country (2020-2031)
3.4.3 North America Molecular Diagnostics for Infectious Diseases Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Molecular Diagnostics for Infectious Diseases Market Facts & Figures by Country
3.5.1 Europe Molecular Diagnostics for Infectious Diseases Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Molecular Diagnostics for Infectious Diseases Sales by Country (2020-2031)
3.5.3 Europe Molecular Diagnostics for Infectious Diseases Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Molecular Diagnostics for Infectious Diseases Market Facts & Figures by Region
3.6.1 Asia Pacific Molecular Diagnostics for Infectious Diseases Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Molecular Diagnostics for Infectious Diseases Sales by Region (2020-2031)
3.6.3 Asia Pacific Molecular Diagnostics for Infectious Diseases Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Molecular Diagnostics for Infectious Diseases Market Facts & Figures by Country
3.7.1 Latin America Molecular Diagnostics for Infectious Diseases Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Molecular Diagnostics for Infectious Diseases Sales by Country (2020-2031)
3.7.3 Latin America Molecular Diagnostics for Infectious Diseases Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Molecular Diagnostics for Infectious Diseases Market Facts & Figures by Country
3.8.1 Middle East and Africa Molecular Diagnostics for Infectious Diseases Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Molecular Diagnostics for Infectious Diseases Sales by Country (2020-2031)
3.8.3 Middle East and Africa Molecular Diagnostics for Infectious Diseases Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Molecular Diagnostics for Infectious Diseases Sales by Type (2020-2031)
4.1.1 Global Molecular Diagnostics for Infectious Diseases Sales by Type (2020-2025)
4.1.2 Global Molecular Diagnostics for Infectious Diseases Sales by Type (2026-2031)
4.1.3 Global Molecular Diagnostics for Infectious Diseases Sales Market Share by Type (2020-2031)
4.2 Global Molecular Diagnostics for Infectious Diseases Revenue by Type (2020-2031)
4.2.1 Global Molecular Diagnostics for Infectious Diseases Revenue by Type (2020-2025)
4.2.2 Global Molecular Diagnostics for Infectious Diseases Revenue by Type (2026-2031)
4.2.3 Global Molecular Diagnostics for Infectious Diseases Revenue Market Share by Type (2020-2031)
4.3 Global Molecular Diagnostics for Infectious Diseases Price by Type (2020-2031)
5 Segment by Application
5.1 Global Molecular Diagnostics for Infectious Diseases Sales by Application (2020-2031)
5.1.1 Global Molecular Diagnostics for Infectious Diseases Sales by Application (2020-2025)
5.1.2 Global Molecular Diagnostics for Infectious Diseases Sales by Application (2026-2031)
5.1.3 Global Molecular Diagnostics for Infectious Diseases Sales Market Share by Application (2020-2031)
5.2 Global Molecular Diagnostics for Infectious Diseases Revenue by Application (2020-2031)
5.2.1 Global Molecular Diagnostics for Infectious Diseases Revenue by Application (2020-2025)
5.2.2 Global Molecular Diagnostics for Infectious Diseases Revenue by Application (2026-2031)
5.2.3 Global Molecular Diagnostics for Infectious Diseases Revenue Market Share by Application (2020-2031)
5.3 Global Molecular Diagnostics for Infectious Diseases Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Roche Diagnostics
6.1.1 Roche Diagnostics Company Information
6.1.2 Roche Diagnostics Description and Business Overview
6.1.3 Roche Diagnostics Molecular Diagnostics for Infectious Diseases Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Roche Diagnostics Molecular Diagnostics for Infectious Diseases Product Portfolio
6.1.5 Roche Diagnostics Recent Developments/Updates
6.2 Illumina
6.2.1 Illumina Company Information
6.2.2 Illumina Description and Business Overview
6.2.3 Illumina Molecular Diagnostics for Infectious Diseases Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Illumina Molecular Diagnostics for Infectious Diseases Product Portfolio
6.2.5 Illumina Recent Developments/Updates
6.3 Qiagen
6.3.1 Qiagen Company Information
6.3.2 Qiagen Description and Business Overview
6.3.3 Qiagen Molecular Diagnostics for Infectious Diseases Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Qiagen Molecular Diagnostics for Infectious Diseases Product Portfolio
6.3.5 Qiagen Recent Developments/Updates
6.4 Abbott Laboratories
6.4.1 Abbott Laboratories Company Information
6.4.2 Abbott Laboratories Description and Business Overview
6.4.3 Abbott Laboratories Molecular Diagnostics for Infectious Diseases Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Abbott Laboratories Molecular Diagnostics for Infectious Diseases Product Portfolio
6.4.5 Abbott Laboratories Recent Developments/Updates
6.5 BioMérieux
6.5.1 BioMérieux Company Information
6.5.2 BioMérieux Description and Business Overview
6.5.3 BioMérieux Molecular Diagnostics for Infectious Diseases Sales, Revenue and Gross Margin (2020-2025)
6.5.4 BioMérieux Molecular Diagnostics for Infectious Diseases Product Portfolio
6.5.5 BioMérieux Recent Developments/Updates
6.6 Cepheid (Danaher)
6.6.1 Cepheid (Danaher) Company Information
6.6.2 Cepheid (Danaher) Description and Business Overview
6.6.3 Cepheid (Danaher) Molecular Diagnostics for Infectious Diseases Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Cepheid (Danaher) Molecular Diagnostics for Infectious Diseases Product Portfolio
6.6.5 Cepheid (Danaher) Recent Developments/Updates
6.7 Thermo Fisher Scientific
6.7.1 Thermo Fisher Scientific Company Information
6.7.2 Thermo Fisher Scientific Description and Business Overview
6.7.3 Thermo Fisher Scientific Molecular Diagnostics for Infectious Diseases Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Thermo Fisher Scientific Molecular Diagnostics for Infectious Diseases Product Portfolio
6.7.5 Thermo Fisher Scientific Recent Developments/Updates
6.8 Hologic
6.8.1 Hologic Company Information
6.8.2 Hologic Description and Business Overview
6.8.3 Hologic Molecular Diagnostics for Infectious Diseases Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Hologic Molecular Diagnostics for Infectious Diseases Product Portfolio
6.8.5 Hologic Recent Developments/Updates
6.9 DiaSorin
6.9.1 DiaSorin Company Information
6.9.2 DiaSorin Description and Business Overview
6.9.3 DiaSorin Molecular Diagnostics for Infectious Diseases Sales, Revenue and Gross Margin (2020-2025)
6.9.4 DiaSorin Molecular Diagnostics for Infectious Diseases Product Portfolio
6.9.5 DiaSorin Recent Developments/Updates
6.10 Luminex
6.10.1 Luminex Company Information
6.10.2 Luminex Description and Business Overview
6.10.3 Luminex Molecular Diagnostics for Infectious Diseases Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Luminex Molecular Diagnostics for Infectious Diseases Product Portfolio
6.10.5 Luminex Recent Developments/Updates
6.11 Hoffmann-La Roche
6.11.1 Hoffmann-La Roche Company Information
6.11.2 Hoffmann-La Roche Description and Business Overview
6.11.3 Hoffmann-La Roche Molecular Diagnostics for Infectious Diseases Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Hoffmann-La Roche Molecular Diagnostics for Infectious Diseases Product Portfolio
6.11.5 Hoffmann-La Roche Recent Developments/Updates
6.12 Biocartis
6.12.1 Biocartis Company Information
6.12.2 Biocartis Description and Business Overview
6.12.3 Biocartis Molecular Diagnostics for Infectious Diseases Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Biocartis Molecular Diagnostics for Infectious Diseases Product Portfolio
6.12.5 Biocartis Recent Developments/Updates
6.13 Nanomix
6.13.1 Nanomix Company Information
6.13.2 Nanomix Description and Business Overview
6.13.3 Nanomix Molecular Diagnostics for Infectious Diseases Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Nanomix Molecular Diagnostics for Infectious Diseases Product Portfolio
6.13.5 Nanomix Recent Developments/Updates
6.14 BioFire Diagnostics
6.14.1 BioFire Diagnostics Company Information
6.14.2 BioFire Diagnostics Description and Business Overview
6.14.3 BioFire Diagnostics Molecular Diagnostics for Infectious Diseases Sales, Revenue and Gross Margin (2020-2025)
6.14.4 BioFire Diagnostics Molecular Diagnostics for Infectious Diseases Product Portfolio
6.14.5 BioFire Diagnostics Recent Developments/Updates
6.15 Seegene
6.15.1 Seegene Company Information
6.15.2 Seegene Description and Business Overview
6.15.3 Seegene Molecular Diagnostics for Infectious Diseases Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Seegene Molecular Diagnostics for Infectious Diseases Product Portfolio
6.15.5 Seegene Recent Developments/Updates
6.16 QuidelOrtho
6.16.1 QuidelOrtho Company Information
6.16.2 QuidelOrtho Description and Business Overview
6.16.3 QuidelOrtho Molecular Diagnostics for Infectious Diseases Sales, Revenue and Gross Margin (2020-2025)
6.16.4 QuidelOrtho Molecular Diagnostics for Infectious Diseases Product Portfolio
6.16.5 QuidelOrtho Recent Developments/Updates
6.17 ZeptoMetrix
6.17.1 ZeptoMetrix Company Information
6.17.2 ZeptoMetrix Description and Business Overview
6.17.3 ZeptoMetrix Molecular Diagnostics for Infectious Diseases Sales, Revenue and Gross Margin (2020-2025)
6.17.4 ZeptoMetrix Molecular Diagnostics for Infectious Diseases Product Portfolio
6.17.5 ZeptoMetrix Recent Developments/Updates
6.18 Sansure
6.18.1 Sansure Company Information
6.18.2 Sansure Description and Business Overview
6.18.3 Sansure Molecular Diagnostics for Infectious Diseases Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Sansure Molecular Diagnostics for Infectious Diseases Product Portfolio
6.18.5 Sansure Recent Developments/Updates
6.19 BGI Genomics
6.19.1 BGI Genomics Company Information
6.19.2 BGI Genomics Description and Business Overview
6.19.3 BGI Genomics Molecular Diagnostics for Infectious Diseases Sales, Revenue and Gross Margin (2020-2025)
6.19.4 BGI Genomics Molecular Diagnostics for Infectious Diseases Product Portfolio
6.19.5 BGI Genomics Recent Developments/Updates
6.20 DaAn Gene
6.20.1 DaAn Gene Company Information
6.20.2 DaAn Gene Description and Business Overview
6.20.3 DaAn Gene Molecular Diagnostics for Infectious Diseases Sales, Revenue and Gross Margin (2020-2025)
6.20.4 DaAn Gene Molecular Diagnostics for Infectious Diseases Product Portfolio
6.20.5 DaAn Gene Recent Developments/Updates
6.21 Kehua Bio-engineering
6.21.1 Kehua Bio-engineering Company Information
6.21.2 Kehua Bio-engineering Description and Business Overview
6.21.3 Kehua Bio-engineering Molecular Diagnostics for Infectious Diseases Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Kehua Bio-engineering Molecular Diagnostics for Infectious Diseases Product Portfolio
6.21.5 Kehua Bio-engineering Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Molecular Diagnostics for Infectious Diseases Industry Chain Analysis
7.2 Molecular Diagnostics for Infectious Diseases Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Molecular Diagnostics for Infectious Diseases Production Mode & Process Analysis
7.4 Molecular Diagnostics for Infectious Diseases Sales and Marketing
7.4.1 Molecular Diagnostics for Infectious Diseases Sales Channels
7.4.2 Molecular Diagnostics for Infectious Diseases Distributors
7.5 Molecular Diagnostics for Infectious Diseases Customer Analysis
8 Molecular Diagnostics for Infectious Diseases Market Dynamics
8.1 Molecular Diagnostics for Infectious Diseases Industry Trends
8.2 Molecular Diagnostics for Infectious Diseases Market Drivers
8.3 Molecular Diagnostics for Infectious Diseases Market Challenges
8.4 Molecular Diagnostics for Infectious Diseases Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Molecular Diagnostics for Infectious Diseases by Type
1.2.1 Global Molecular Diagnostics for Infectious Diseases Market Value Comparison by Type (2024 VS 2031)
1.2.2 Respiratory Tract Infections
1.2.3 Reproductive Tract Infections
1.2.4 Blood-borne Infections (BBIs)
1.2.5 Gastrointestinal Infections (GIIs)
1.2.6 Other Infections
1.3 Molecular Diagnostics for Infectious Diseases by Application
1.3.1 Global Molecular Diagnostics for Infectious Diseases Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Diagnostic Laboratories
1.4 Global Molecular Diagnostics for Infectious Diseases Market Size Estimates and Forecasts
1.4.1 Global Molecular Diagnostics for Infectious Diseases Revenue 2020-2031
1.4.2 Global Molecular Diagnostics for Infectious Diseases Sales 2020-2031
1.4.3 Global Molecular Diagnostics for Infectious Diseases Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Molecular Diagnostics for Infectious Diseases Market Competition by Manufacturers
2.1 Global Molecular Diagnostics for Infectious Diseases Sales Market Share by Manufacturers (2020-2025)
2.2 Global Molecular Diagnostics for Infectious Diseases Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Molecular Diagnostics for Infectious Diseases Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Molecular Diagnostics for Infectious Diseases, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Molecular Diagnostics for Infectious Diseases, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Molecular Diagnostics for Infectious Diseases, Product Type & Application
2.7 Global Key Manufacturers of Molecular Diagnostics for Infectious Diseases, Date of Enter into This Industry
2.8 Global Molecular Diagnostics for Infectious Diseases Market Competitive Situation and Trends
2.8.1 Global Molecular Diagnostics for Infectious Diseases Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Molecular Diagnostics for Infectious Diseases Players Market Share by Revenue
2.8.3 Global Molecular Diagnostics for Infectious Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Molecular Diagnostics for Infectious Diseases Market Scenario by Region
3.1 Global Molecular Diagnostics for Infectious Diseases Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Molecular Diagnostics for Infectious Diseases Sales by Region: 2020-2031
3.2.1 Global Molecular Diagnostics for Infectious Diseases Sales by Region: 2020-2025
3.2.2 Global Molecular Diagnostics for Infectious Diseases Sales by Region: 2026-2031
3.3 Global Molecular Diagnostics for Infectious Diseases Revenue by Region: 2020-2031
3.3.1 Global Molecular Diagnostics for Infectious Diseases Revenue by Region: 2020-2025
3.3.2 Global Molecular Diagnostics for Infectious Diseases Revenue by Region: 2026-2031
3.4 North America Molecular Diagnostics for Infectious Diseases Market Facts & Figures by Country
3.4.1 North America Molecular Diagnostics for Infectious Diseases Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Molecular Diagnostics for Infectious Diseases Sales by Country (2020-2031)
3.4.3 North America Molecular Diagnostics for Infectious Diseases Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Molecular Diagnostics for Infectious Diseases Market Facts & Figures by Country
3.5.1 Europe Molecular Diagnostics for Infectious Diseases Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Molecular Diagnostics for Infectious Diseases Sales by Country (2020-2031)
3.5.3 Europe Molecular Diagnostics for Infectious Diseases Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Molecular Diagnostics for Infectious Diseases Market Facts & Figures by Region
3.6.1 Asia Pacific Molecular Diagnostics for Infectious Diseases Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Molecular Diagnostics for Infectious Diseases Sales by Region (2020-2031)
3.6.3 Asia Pacific Molecular Diagnostics for Infectious Diseases Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Molecular Diagnostics for Infectious Diseases Market Facts & Figures by Country
3.7.1 Latin America Molecular Diagnostics for Infectious Diseases Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Molecular Diagnostics for Infectious Diseases Sales by Country (2020-2031)
3.7.3 Latin America Molecular Diagnostics for Infectious Diseases Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Molecular Diagnostics for Infectious Diseases Market Facts & Figures by Country
3.8.1 Middle East and Africa Molecular Diagnostics for Infectious Diseases Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Molecular Diagnostics for Infectious Diseases Sales by Country (2020-2031)
3.8.3 Middle East and Africa Molecular Diagnostics for Infectious Diseases Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Molecular Diagnostics for Infectious Diseases Sales by Type (2020-2031)
4.1.1 Global Molecular Diagnostics for Infectious Diseases Sales by Type (2020-2025)
4.1.2 Global Molecular Diagnostics for Infectious Diseases Sales by Type (2026-2031)
4.1.3 Global Molecular Diagnostics for Infectious Diseases Sales Market Share by Type (2020-2031)
4.2 Global Molecular Diagnostics for Infectious Diseases Revenue by Type (2020-2031)
4.2.1 Global Molecular Diagnostics for Infectious Diseases Revenue by Type (2020-2025)
4.2.2 Global Molecular Diagnostics for Infectious Diseases Revenue by Type (2026-2031)
4.2.3 Global Molecular Diagnostics for Infectious Diseases Revenue Market Share by Type (2020-2031)
4.3 Global Molecular Diagnostics for Infectious Diseases Price by Type (2020-2031)
5 Segment by Application
5.1 Global Molecular Diagnostics for Infectious Diseases Sales by Application (2020-2031)
5.1.1 Global Molecular Diagnostics for Infectious Diseases Sales by Application (2020-2025)
5.1.2 Global Molecular Diagnostics for Infectious Diseases Sales by Application (2026-2031)
5.1.3 Global Molecular Diagnostics for Infectious Diseases Sales Market Share by Application (2020-2031)
5.2 Global Molecular Diagnostics for Infectious Diseases Revenue by Application (2020-2031)
5.2.1 Global Molecular Diagnostics for Infectious Diseases Revenue by Application (2020-2025)
5.2.2 Global Molecular Diagnostics for Infectious Diseases Revenue by Application (2026-2031)
5.2.3 Global Molecular Diagnostics for Infectious Diseases Revenue Market Share by Application (2020-2031)
5.3 Global Molecular Diagnostics for Infectious Diseases Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Roche Diagnostics
6.1.1 Roche Diagnostics Company Information
6.1.2 Roche Diagnostics Description and Business Overview
6.1.3 Roche Diagnostics Molecular Diagnostics for Infectious Diseases Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Roche Diagnostics Molecular Diagnostics for Infectious Diseases Product Portfolio
6.1.5 Roche Diagnostics Recent Developments/Updates
6.2 Illumina
6.2.1 Illumina Company Information
6.2.2 Illumina Description and Business Overview
6.2.3 Illumina Molecular Diagnostics for Infectious Diseases Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Illumina Molecular Diagnostics for Infectious Diseases Product Portfolio
6.2.5 Illumina Recent Developments/Updates
6.3 Qiagen
6.3.1 Qiagen Company Information
6.3.2 Qiagen Description and Business Overview
6.3.3 Qiagen Molecular Diagnostics for Infectious Diseases Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Qiagen Molecular Diagnostics for Infectious Diseases Product Portfolio
6.3.5 Qiagen Recent Developments/Updates
6.4 Abbott Laboratories
6.4.1 Abbott Laboratories Company Information
6.4.2 Abbott Laboratories Description and Business Overview
6.4.3 Abbott Laboratories Molecular Diagnostics for Infectious Diseases Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Abbott Laboratories Molecular Diagnostics for Infectious Diseases Product Portfolio
6.4.5 Abbott Laboratories Recent Developments/Updates
6.5 BioMérieux
6.5.1 BioMérieux Company Information
6.5.2 BioMérieux Description and Business Overview
6.5.3 BioMérieux Molecular Diagnostics for Infectious Diseases Sales, Revenue and Gross Margin (2020-2025)
6.5.4 BioMérieux Molecular Diagnostics for Infectious Diseases Product Portfolio
6.5.5 BioMérieux Recent Developments/Updates
6.6 Cepheid (Danaher)
6.6.1 Cepheid (Danaher) Company Information
6.6.2 Cepheid (Danaher) Description and Business Overview
6.6.3 Cepheid (Danaher) Molecular Diagnostics for Infectious Diseases Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Cepheid (Danaher) Molecular Diagnostics for Infectious Diseases Product Portfolio
6.6.5 Cepheid (Danaher) Recent Developments/Updates
6.7 Thermo Fisher Scientific
6.7.1 Thermo Fisher Scientific Company Information
6.7.2 Thermo Fisher Scientific Description and Business Overview
6.7.3 Thermo Fisher Scientific Molecular Diagnostics for Infectious Diseases Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Thermo Fisher Scientific Molecular Diagnostics for Infectious Diseases Product Portfolio
6.7.5 Thermo Fisher Scientific Recent Developments/Updates
6.8 Hologic
6.8.1 Hologic Company Information
6.8.2 Hologic Description and Business Overview
6.8.3 Hologic Molecular Diagnostics for Infectious Diseases Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Hologic Molecular Diagnostics for Infectious Diseases Product Portfolio
6.8.5 Hologic Recent Developments/Updates
6.9 DiaSorin
6.9.1 DiaSorin Company Information
6.9.2 DiaSorin Description and Business Overview
6.9.3 DiaSorin Molecular Diagnostics for Infectious Diseases Sales, Revenue and Gross Margin (2020-2025)
6.9.4 DiaSorin Molecular Diagnostics for Infectious Diseases Product Portfolio
6.9.5 DiaSorin Recent Developments/Updates
6.10 Luminex
6.10.1 Luminex Company Information
6.10.2 Luminex Description and Business Overview
6.10.3 Luminex Molecular Diagnostics for Infectious Diseases Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Luminex Molecular Diagnostics for Infectious Diseases Product Portfolio
6.10.5 Luminex Recent Developments/Updates
6.11 Hoffmann-La Roche
6.11.1 Hoffmann-La Roche Company Information
6.11.2 Hoffmann-La Roche Description and Business Overview
6.11.3 Hoffmann-La Roche Molecular Diagnostics for Infectious Diseases Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Hoffmann-La Roche Molecular Diagnostics for Infectious Diseases Product Portfolio
6.11.5 Hoffmann-La Roche Recent Developments/Updates
6.12 Biocartis
6.12.1 Biocartis Company Information
6.12.2 Biocartis Description and Business Overview
6.12.3 Biocartis Molecular Diagnostics for Infectious Diseases Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Biocartis Molecular Diagnostics for Infectious Diseases Product Portfolio
6.12.5 Biocartis Recent Developments/Updates
6.13 Nanomix
6.13.1 Nanomix Company Information
6.13.2 Nanomix Description and Business Overview
6.13.3 Nanomix Molecular Diagnostics for Infectious Diseases Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Nanomix Molecular Diagnostics for Infectious Diseases Product Portfolio
6.13.5 Nanomix Recent Developments/Updates
6.14 BioFire Diagnostics
6.14.1 BioFire Diagnostics Company Information
6.14.2 BioFire Diagnostics Description and Business Overview
6.14.3 BioFire Diagnostics Molecular Diagnostics for Infectious Diseases Sales, Revenue and Gross Margin (2020-2025)
6.14.4 BioFire Diagnostics Molecular Diagnostics for Infectious Diseases Product Portfolio
6.14.5 BioFire Diagnostics Recent Developments/Updates
6.15 Seegene
6.15.1 Seegene Company Information
6.15.2 Seegene Description and Business Overview
6.15.3 Seegene Molecular Diagnostics for Infectious Diseases Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Seegene Molecular Diagnostics for Infectious Diseases Product Portfolio
6.15.5 Seegene Recent Developments/Updates
6.16 QuidelOrtho
6.16.1 QuidelOrtho Company Information
6.16.2 QuidelOrtho Description and Business Overview
6.16.3 QuidelOrtho Molecular Diagnostics for Infectious Diseases Sales, Revenue and Gross Margin (2020-2025)
6.16.4 QuidelOrtho Molecular Diagnostics for Infectious Diseases Product Portfolio
6.16.5 QuidelOrtho Recent Developments/Updates
6.17 ZeptoMetrix
6.17.1 ZeptoMetrix Company Information
6.17.2 ZeptoMetrix Description and Business Overview
6.17.3 ZeptoMetrix Molecular Diagnostics for Infectious Diseases Sales, Revenue and Gross Margin (2020-2025)
6.17.4 ZeptoMetrix Molecular Diagnostics for Infectious Diseases Product Portfolio
6.17.5 ZeptoMetrix Recent Developments/Updates
6.18 Sansure
6.18.1 Sansure Company Information
6.18.2 Sansure Description and Business Overview
6.18.3 Sansure Molecular Diagnostics for Infectious Diseases Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Sansure Molecular Diagnostics for Infectious Diseases Product Portfolio
6.18.5 Sansure Recent Developments/Updates
6.19 BGI Genomics
6.19.1 BGI Genomics Company Information
6.19.2 BGI Genomics Description and Business Overview
6.19.3 BGI Genomics Molecular Diagnostics for Infectious Diseases Sales, Revenue and Gross Margin (2020-2025)
6.19.4 BGI Genomics Molecular Diagnostics for Infectious Diseases Product Portfolio
6.19.5 BGI Genomics Recent Developments/Updates
6.20 DaAn Gene
6.20.1 DaAn Gene Company Information
6.20.2 DaAn Gene Description and Business Overview
6.20.3 DaAn Gene Molecular Diagnostics for Infectious Diseases Sales, Revenue and Gross Margin (2020-2025)
6.20.4 DaAn Gene Molecular Diagnostics for Infectious Diseases Product Portfolio
6.20.5 DaAn Gene Recent Developments/Updates
6.21 Kehua Bio-engineering
6.21.1 Kehua Bio-engineering Company Information
6.21.2 Kehua Bio-engineering Description and Business Overview
6.21.3 Kehua Bio-engineering Molecular Diagnostics for Infectious Diseases Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Kehua Bio-engineering Molecular Diagnostics for Infectious Diseases Product Portfolio
6.21.5 Kehua Bio-engineering Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Molecular Diagnostics for Infectious Diseases Industry Chain Analysis
7.2 Molecular Diagnostics for Infectious Diseases Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Molecular Diagnostics for Infectious Diseases Production Mode & Process Analysis
7.4 Molecular Diagnostics for Infectious Diseases Sales and Marketing
7.4.1 Molecular Diagnostics for Infectious Diseases Sales Channels
7.4.2 Molecular Diagnostics for Infectious Diseases Distributors
7.5 Molecular Diagnostics for Infectious Diseases Customer Analysis
8 Molecular Diagnostics for Infectious Diseases Market Dynamics
8.1 Molecular Diagnostics for Infectious Diseases Industry Trends
8.2 Molecular Diagnostics for Infectious Diseases Market Drivers
8.3 Molecular Diagnostics for Infectious Diseases Market Challenges
8.4 Molecular Diagnostics for Infectious Diseases Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Molecular Diagnostics for Infectious Diseases Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Molecular Diagnostics for Infectious Diseases Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Molecular Diagnostics for Infectious Diseases Market Competitive Situation by Manufacturers in 2024
Table 4. Global Molecular Diagnostics for Infectious Diseases Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Molecular Diagnostics for Infectious Diseases Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Molecular Diagnostics for Infectious Diseases Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Molecular Diagnostics for Infectious Diseases Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Molecular Diagnostics for Infectious Diseases Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Molecular Diagnostics for Infectious Diseases, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Molecular Diagnostics for Infectious Diseases, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Molecular Diagnostics for Infectious Diseases, Product Type & Application
Table 12. Global Key Manufacturers of Molecular Diagnostics for Infectious Diseases, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Molecular Diagnostics for Infectious Diseases by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics for Infectious Diseases as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Molecular Diagnostics for Infectious Diseases Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Molecular Diagnostics for Infectious Diseases Sales by Region (2020-2025) & (K Units)
Table 18. Global Molecular Diagnostics for Infectious Diseases Sales Market Share by Region (2020-2025)
Table 19. Global Molecular Diagnostics for Infectious Diseases Sales by Region (2026-2031) & (K Units)
Table 20. Global Molecular Diagnostics for Infectious Diseases Sales Market Share by Region (2026-2031)
Table 21. Global Molecular Diagnostics for Infectious Diseases Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Molecular Diagnostics for Infectious Diseases Revenue Market Share by Region (2020-2025)
Table 23. Global Molecular Diagnostics for Infectious Diseases Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Molecular Diagnostics for Infectious Diseases Revenue Market Share by Region (2026-2031)
Table 25. North America Molecular Diagnostics for Infectious Diseases Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Molecular Diagnostics for Infectious Diseases Sales by Country (2020-2025) & (K Units)
Table 27. North America Molecular Diagnostics for Infectious Diseases Sales by Country (2026-2031) & (K Units)
Table 28. North America Molecular Diagnostics for Infectious Diseases Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Molecular Diagnostics for Infectious Diseases Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Molecular Diagnostics for Infectious Diseases Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Molecular Diagnostics for Infectious Diseases Sales by Country (2020-2025) & (K Units)
Table 32. Europe Molecular Diagnostics for Infectious Diseases Sales by Country (2026-2031) & (K Units)
Table 33. Europe Molecular Diagnostics for Infectious Diseases Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Molecular Diagnostics for Infectious Diseases Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Molecular Diagnostics for Infectious Diseases Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Molecular Diagnostics for Infectious Diseases Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Molecular Diagnostics for Infectious Diseases Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Molecular Diagnostics for Infectious Diseases Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Molecular Diagnostics for Infectious Diseases Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Molecular Diagnostics for Infectious Diseases Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Molecular Diagnostics for Infectious Diseases Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Molecular Diagnostics for Infectious Diseases Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Molecular Diagnostics for Infectious Diseases Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Molecular Diagnostics for Infectious Diseases Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Molecular Diagnostics for Infectious Diseases Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Molecular Diagnostics for Infectious Diseases Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Molecular Diagnostics for Infectious Diseases Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Molecular Diagnostics for Infectious Diseases Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Molecular Diagnostics for Infectious Diseases Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Molecular Diagnostics for Infectious Diseases Sales (K Units) by Type (2020-2025)
Table 51. Global Molecular Diagnostics for Infectious Diseases Sales (K Units) by Type (2026-2031)
Table 52. Global Molecular Diagnostics for Infectious Diseases Sales Market Share by Type (2020-2025)
Table 53. Global Molecular Diagnostics for Infectious Diseases Sales Market Share by Type (2026-2031)
Table 54. Global Molecular Diagnostics for Infectious Diseases Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Molecular Diagnostics for Infectious Diseases Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Molecular Diagnostics for Infectious Diseases Revenue Market Share by Type (2020-2025)
Table 57. Global Molecular Diagnostics for Infectious Diseases Revenue Market Share by Type (2026-2031)
Table 58. Global Molecular Diagnostics for Infectious Diseases Price (US$/Unit) by Type (2020-2025)
Table 59. Global Molecular Diagnostics for Infectious Diseases Price (US$/Unit) by Type (2026-2031)
Table 60. Global Molecular Diagnostics for Infectious Diseases Sales (K Units) by Application (2020-2025)
Table 61. Global Molecular Diagnostics for Infectious Diseases Sales (K Units) by Application (2026-2031)
Table 62. Global Molecular Diagnostics for Infectious Diseases Sales Market Share by Application (2020-2025)
Table 63. Global Molecular Diagnostics for Infectious Diseases Sales Market Share by Application (2026-2031)
Table 64. Global Molecular Diagnostics for Infectious Diseases Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Molecular Diagnostics for Infectious Diseases Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Molecular Diagnostics for Infectious Diseases Revenue Market Share by Application (2020-2025)
Table 67. Global Molecular Diagnostics for Infectious Diseases Revenue Market Share by Application (2026-2031)
Table 68. Global Molecular Diagnostics for Infectious Diseases Price (US$/Unit) by Application (2020-2025)
Table 69. Global Molecular Diagnostics for Infectious Diseases Price (US$/Unit) by Application (2026-2031)
Table 70. Roche Diagnostics Company Information
Table 71. Roche Diagnostics Description and Business Overview
Table 72. Roche Diagnostics Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Roche Diagnostics Molecular Diagnostics for Infectious Diseases Product
Table 74. Roche Diagnostics Recent Developments/Updates
Table 75. Illumina Company Information
Table 76. Illumina Description and Business Overview
Table 77. Illumina Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Illumina Molecular Diagnostics for Infectious Diseases Product
Table 79. Illumina Recent Developments/Updates
Table 80. Qiagen Company Information
Table 81. Qiagen Description and Business Overview
Table 82. Qiagen Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Qiagen Molecular Diagnostics for Infectious Diseases Product
Table 84. Qiagen Recent Developments/Updates
Table 85. Abbott Laboratories Company Information
Table 86. Abbott Laboratories Description and Business Overview
Table 87. Abbott Laboratories Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Abbott Laboratories Molecular Diagnostics for Infectious Diseases Product
Table 89. Abbott Laboratories Recent Developments/Updates
Table 90. BioMérieux Company Information
Table 91. BioMérieux Description and Business Overview
Table 92. BioMérieux Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. BioMérieux Molecular Diagnostics for Infectious Diseases Product
Table 94. BioMérieux Recent Developments/Updates
Table 95. Cepheid (Danaher) Company Information
Table 96. Cepheid (Danaher) Description and Business Overview
Table 97. Cepheid (Danaher) Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Cepheid (Danaher) Molecular Diagnostics for Infectious Diseases Product
Table 99. Cepheid (Danaher) Recent Developments/Updates
Table 100. Thermo Fisher Scientific Company Information
Table 101. Thermo Fisher Scientific Description and Business Overview
Table 102. Thermo Fisher Scientific Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Thermo Fisher Scientific Molecular Diagnostics for Infectious Diseases Product
Table 104. Thermo Fisher Scientific Recent Developments/Updates
Table 105. Hologic Company Information
Table 106. Hologic Description and Business Overview
Table 107. Hologic Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Hologic Molecular Diagnostics for Infectious Diseases Product
Table 109. Hologic Recent Developments/Updates
Table 110. DiaSorin Company Information
Table 111. DiaSorin Description and Business Overview
Table 112. DiaSorin Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. DiaSorin Molecular Diagnostics for Infectious Diseases Product
Table 114. DiaSorin Recent Developments/Updates
Table 115. Luminex Company Information
Table 116. Luminex Description and Business Overview
Table 117. Luminex Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Luminex Molecular Diagnostics for Infectious Diseases Product
Table 119. Luminex Recent Developments/Updates
Table 120. Hoffmann-La Roche Company Information
Table 121. Hoffmann-La Roche Description and Business Overview
Table 122. Hoffmann-La Roche Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Hoffmann-La Roche Molecular Diagnostics for Infectious Diseases Product
Table 124. Hoffmann-La Roche Recent Developments/Updates
Table 125. Biocartis Company Information
Table 126. Biocartis Description and Business Overview
Table 127. Biocartis Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Biocartis Molecular Diagnostics for Infectious Diseases Product
Table 129. Biocartis Recent Developments/Updates
Table 130. Nanomix Company Information
Table 131. Nanomix Description and Business Overview
Table 132. Nanomix Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Nanomix Molecular Diagnostics for Infectious Diseases Product
Table 134. Nanomix Recent Developments/Updates
Table 135. BioFire Diagnostics Company Information
Table 136. BioFire Diagnostics Description and Business Overview
Table 137. BioFire Diagnostics Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. BioFire Diagnostics Molecular Diagnostics for Infectious Diseases Product
Table 139. BioFire Diagnostics Recent Developments/Updates
Table 140. Seegene Company Information
Table 141. Seegene Description and Business Overview
Table 142. Seegene Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Seegene Molecular Diagnostics for Infectious Diseases Product
Table 144. Seegene Recent Developments/Updates
Table 145. QuidelOrtho Company Information
Table 146. QuidelOrtho Description and Business Overview
Table 147. QuidelOrtho Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. QuidelOrtho Molecular Diagnostics for Infectious Diseases Product
Table 149. QuidelOrtho Recent Developments/Updates
Table 150. ZeptoMetrix Company Information
Table 151. ZeptoMetrix Description and Business Overview
Table 152. ZeptoMetrix Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. ZeptoMetrix Molecular Diagnostics for Infectious Diseases Product
Table 154. ZeptoMetrix Recent Developments/Updates
Table 155. Sansure Company Information
Table 156. Sansure Description and Business Overview
Table 157. Sansure Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Sansure Molecular Diagnostics for Infectious Diseases Product
Table 159. Sansure Recent Developments/Updates
Table 160. BGI Genomics Company Information
Table 161. BGI Genomics Description and Business Overview
Table 162. BGI Genomics Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. BGI Genomics Molecular Diagnostics for Infectious Diseases Product
Table 164. BGI Genomics Recent Developments/Updates
Table 165. DaAn Gene Company Information
Table 166. DaAn Gene Description and Business Overview
Table 167. DaAn Gene Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. DaAn Gene Molecular Diagnostics for Infectious Diseases Product
Table 169. DaAn Gene Recent Developments/Updates
Table 170. Kehua Bio-engineering Company Information
Table 171. Kehua Bio-engineering Description and Business Overview
Table 172. Kehua Bio-engineering Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 173. Kehua Bio-engineering Molecular Diagnostics for Infectious Diseases Product
Table 174. Kehua Bio-engineering Recent Developments/Updates
Table 175. Key Raw Materials Lists
Table 176. Raw Materials Key Suppliers Lists
Table 177. Molecular Diagnostics for Infectious Diseases Distributors List
Table 178. Molecular Diagnostics for Infectious Diseases Customers List
Table 179. Molecular Diagnostics for Infectious Diseases Market Trends
Table 180. Molecular Diagnostics for Infectious Diseases Market Drivers
Table 181. Molecular Diagnostics for Infectious Diseases Market Challenges
Table 182. Molecular Diagnostics for Infectious Diseases Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
Table 186. Authors List of This Report
List of Figures
Figure 1. Product Picture of Molecular Diagnostics for Infectious Diseases
Figure 2. Global Molecular Diagnostics for Infectious Diseases Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Molecular Diagnostics for Infectious Diseases Market Share by Type: 2024 & 2031
Figure 4. Respiratory Tract Infections Product Picture
Figure 5. Reproductive Tract Infections Product Picture
Figure 6. Blood-borne Infections (BBIs) Product Picture
Figure 7. Gastrointestinal Infections (GIIs) Product Picture
Figure 8. Other Infections Product Picture
Figure 9. Global Molecular Diagnostics for Infectious Diseases Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Molecular Diagnostics for Infectious Diseases Market Share by Application: 2024 & 2031
Figure 11. Hospital
Figure 12. Diagnostic Laboratories
Figure 13. Global Molecular Diagnostics for Infectious Diseases Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Molecular Diagnostics for Infectious Diseases Market Size (2020-2031) & (US$ Million)
Figure 15. Global Molecular Diagnostics for Infectious Diseases Sales (2020-2031) & (K Units)
Figure 16. Global Molecular Diagnostics for Infectious Diseases Average Price (US$/Unit) & (2020-2031)
Figure 17. Molecular Diagnostics for Infectious Diseases Report Years Considered
Figure 18. Molecular Diagnostics for Infectious Diseases Sales Share by Manufacturers in 2024
Figure 19. Global Molecular Diagnostics for Infectious Diseases Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Molecular Diagnostics for Infectious Diseases Players: Market Share by Revenue in Molecular Diagnostics for Infectious Diseases in 2024
Figure 21. Molecular Diagnostics for Infectious Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Molecular Diagnostics for Infectious Diseases Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Molecular Diagnostics for Infectious Diseases Sales Market Share by Country (2020-2031)
Figure 24. North America Molecular Diagnostics for Infectious Diseases Revenue Market Share by Country (2020-2031)
Figure 25. United States Molecular Diagnostics for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Molecular Diagnostics for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Molecular Diagnostics for Infectious Diseases Sales Market Share by Country (2020-2031)
Figure 28. Europe Molecular Diagnostics for Infectious Diseases Revenue Market Share by Country (2020-2031)
Figure 29. Germany Molecular Diagnostics for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Molecular Diagnostics for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Molecular Diagnostics for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Molecular Diagnostics for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Molecular Diagnostics for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Molecular Diagnostics for Infectious Diseases Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Molecular Diagnostics for Infectious Diseases Revenue Market Share by Region (2020-2031)
Figure 36. China Molecular Diagnostics for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Molecular Diagnostics for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Molecular Diagnostics for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Molecular Diagnostics for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Molecular Diagnostics for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Molecular Diagnostics for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Molecular Diagnostics for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Molecular Diagnostics for Infectious Diseases Sales Market Share by Country (2020-2031)
Figure 44. Latin America Molecular Diagnostics for Infectious Diseases Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Molecular Diagnostics for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Molecular Diagnostics for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Molecular Diagnostics for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Molecular Diagnostics for Infectious Diseases Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Molecular Diagnostics for Infectious Diseases Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Molecular Diagnostics for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Molecular Diagnostics for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Molecular Diagnostics for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Molecular Diagnostics for Infectious Diseases by Type (2020-2031)
Figure 54. Global Revenue Market Share of Molecular Diagnostics for Infectious Diseases by Type (2020-2031)
Figure 55. Global Molecular Diagnostics for Infectious Diseases Price (US$/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Molecular Diagnostics for Infectious Diseases by Application (2020-2031)
Figure 57. Global Revenue Market Share of Molecular Diagnostics for Infectious Diseases by Application (2020-2031)
Figure 58. Global Molecular Diagnostics for Infectious Diseases Price (US$/Unit) by Application (2020-2031)
Figure 59. Molecular Diagnostics for Infectious Diseases Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Molecular Diagnostics for Infectious Diseases Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Molecular Diagnostics for Infectious Diseases Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Molecular Diagnostics for Infectious Diseases Market Competitive Situation by Manufacturers in 2024
Table 4. Global Molecular Diagnostics for Infectious Diseases Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Molecular Diagnostics for Infectious Diseases Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Molecular Diagnostics for Infectious Diseases Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Molecular Diagnostics for Infectious Diseases Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Molecular Diagnostics for Infectious Diseases Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Molecular Diagnostics for Infectious Diseases, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Molecular Diagnostics for Infectious Diseases, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Molecular Diagnostics for Infectious Diseases, Product Type & Application
Table 12. Global Key Manufacturers of Molecular Diagnostics for Infectious Diseases, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Molecular Diagnostics for Infectious Diseases by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics for Infectious Diseases as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Molecular Diagnostics for Infectious Diseases Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Molecular Diagnostics for Infectious Diseases Sales by Region (2020-2025) & (K Units)
Table 18. Global Molecular Diagnostics for Infectious Diseases Sales Market Share by Region (2020-2025)
Table 19. Global Molecular Diagnostics for Infectious Diseases Sales by Region (2026-2031) & (K Units)
Table 20. Global Molecular Diagnostics for Infectious Diseases Sales Market Share by Region (2026-2031)
Table 21. Global Molecular Diagnostics for Infectious Diseases Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Molecular Diagnostics for Infectious Diseases Revenue Market Share by Region (2020-2025)
Table 23. Global Molecular Diagnostics for Infectious Diseases Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Molecular Diagnostics for Infectious Diseases Revenue Market Share by Region (2026-2031)
Table 25. North America Molecular Diagnostics for Infectious Diseases Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Molecular Diagnostics for Infectious Diseases Sales by Country (2020-2025) & (K Units)
Table 27. North America Molecular Diagnostics for Infectious Diseases Sales by Country (2026-2031) & (K Units)
Table 28. North America Molecular Diagnostics for Infectious Diseases Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Molecular Diagnostics for Infectious Diseases Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Molecular Diagnostics for Infectious Diseases Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Molecular Diagnostics for Infectious Diseases Sales by Country (2020-2025) & (K Units)
Table 32. Europe Molecular Diagnostics for Infectious Diseases Sales by Country (2026-2031) & (K Units)
Table 33. Europe Molecular Diagnostics for Infectious Diseases Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Molecular Diagnostics for Infectious Diseases Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Molecular Diagnostics for Infectious Diseases Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Molecular Diagnostics for Infectious Diseases Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Molecular Diagnostics for Infectious Diseases Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Molecular Diagnostics for Infectious Diseases Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Molecular Diagnostics for Infectious Diseases Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Molecular Diagnostics for Infectious Diseases Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Molecular Diagnostics for Infectious Diseases Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Molecular Diagnostics for Infectious Diseases Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Molecular Diagnostics for Infectious Diseases Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Molecular Diagnostics for Infectious Diseases Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Molecular Diagnostics for Infectious Diseases Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Molecular Diagnostics for Infectious Diseases Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Molecular Diagnostics for Infectious Diseases Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Molecular Diagnostics for Infectious Diseases Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Molecular Diagnostics for Infectious Diseases Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Molecular Diagnostics for Infectious Diseases Sales (K Units) by Type (2020-2025)
Table 51. Global Molecular Diagnostics for Infectious Diseases Sales (K Units) by Type (2026-2031)
Table 52. Global Molecular Diagnostics for Infectious Diseases Sales Market Share by Type (2020-2025)
Table 53. Global Molecular Diagnostics for Infectious Diseases Sales Market Share by Type (2026-2031)
Table 54. Global Molecular Diagnostics for Infectious Diseases Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Molecular Diagnostics for Infectious Diseases Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Molecular Diagnostics for Infectious Diseases Revenue Market Share by Type (2020-2025)
Table 57. Global Molecular Diagnostics for Infectious Diseases Revenue Market Share by Type (2026-2031)
Table 58. Global Molecular Diagnostics for Infectious Diseases Price (US$/Unit) by Type (2020-2025)
Table 59. Global Molecular Diagnostics for Infectious Diseases Price (US$/Unit) by Type (2026-2031)
Table 60. Global Molecular Diagnostics for Infectious Diseases Sales (K Units) by Application (2020-2025)
Table 61. Global Molecular Diagnostics for Infectious Diseases Sales (K Units) by Application (2026-2031)
Table 62. Global Molecular Diagnostics for Infectious Diseases Sales Market Share by Application (2020-2025)
Table 63. Global Molecular Diagnostics for Infectious Diseases Sales Market Share by Application (2026-2031)
Table 64. Global Molecular Diagnostics for Infectious Diseases Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Molecular Diagnostics for Infectious Diseases Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Molecular Diagnostics for Infectious Diseases Revenue Market Share by Application (2020-2025)
Table 67. Global Molecular Diagnostics for Infectious Diseases Revenue Market Share by Application (2026-2031)
Table 68. Global Molecular Diagnostics for Infectious Diseases Price (US$/Unit) by Application (2020-2025)
Table 69. Global Molecular Diagnostics for Infectious Diseases Price (US$/Unit) by Application (2026-2031)
Table 70. Roche Diagnostics Company Information
Table 71. Roche Diagnostics Description and Business Overview
Table 72. Roche Diagnostics Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Roche Diagnostics Molecular Diagnostics for Infectious Diseases Product
Table 74. Roche Diagnostics Recent Developments/Updates
Table 75. Illumina Company Information
Table 76. Illumina Description and Business Overview
Table 77. Illumina Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Illumina Molecular Diagnostics for Infectious Diseases Product
Table 79. Illumina Recent Developments/Updates
Table 80. Qiagen Company Information
Table 81. Qiagen Description and Business Overview
Table 82. Qiagen Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Qiagen Molecular Diagnostics for Infectious Diseases Product
Table 84. Qiagen Recent Developments/Updates
Table 85. Abbott Laboratories Company Information
Table 86. Abbott Laboratories Description and Business Overview
Table 87. Abbott Laboratories Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Abbott Laboratories Molecular Diagnostics for Infectious Diseases Product
Table 89. Abbott Laboratories Recent Developments/Updates
Table 90. BioMérieux Company Information
Table 91. BioMérieux Description and Business Overview
Table 92. BioMérieux Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. BioMérieux Molecular Diagnostics for Infectious Diseases Product
Table 94. BioMérieux Recent Developments/Updates
Table 95. Cepheid (Danaher) Company Information
Table 96. Cepheid (Danaher) Description and Business Overview
Table 97. Cepheid (Danaher) Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Cepheid (Danaher) Molecular Diagnostics for Infectious Diseases Product
Table 99. Cepheid (Danaher) Recent Developments/Updates
Table 100. Thermo Fisher Scientific Company Information
Table 101. Thermo Fisher Scientific Description and Business Overview
Table 102. Thermo Fisher Scientific Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Thermo Fisher Scientific Molecular Diagnostics for Infectious Diseases Product
Table 104. Thermo Fisher Scientific Recent Developments/Updates
Table 105. Hologic Company Information
Table 106. Hologic Description and Business Overview
Table 107. Hologic Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Hologic Molecular Diagnostics for Infectious Diseases Product
Table 109. Hologic Recent Developments/Updates
Table 110. DiaSorin Company Information
Table 111. DiaSorin Description and Business Overview
Table 112. DiaSorin Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. DiaSorin Molecular Diagnostics for Infectious Diseases Product
Table 114. DiaSorin Recent Developments/Updates
Table 115. Luminex Company Information
Table 116. Luminex Description and Business Overview
Table 117. Luminex Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Luminex Molecular Diagnostics for Infectious Diseases Product
Table 119. Luminex Recent Developments/Updates
Table 120. Hoffmann-La Roche Company Information
Table 121. Hoffmann-La Roche Description and Business Overview
Table 122. Hoffmann-La Roche Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Hoffmann-La Roche Molecular Diagnostics for Infectious Diseases Product
Table 124. Hoffmann-La Roche Recent Developments/Updates
Table 125. Biocartis Company Information
Table 126. Biocartis Description and Business Overview
Table 127. Biocartis Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Biocartis Molecular Diagnostics for Infectious Diseases Product
Table 129. Biocartis Recent Developments/Updates
Table 130. Nanomix Company Information
Table 131. Nanomix Description and Business Overview
Table 132. Nanomix Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Nanomix Molecular Diagnostics for Infectious Diseases Product
Table 134. Nanomix Recent Developments/Updates
Table 135. BioFire Diagnostics Company Information
Table 136. BioFire Diagnostics Description and Business Overview
Table 137. BioFire Diagnostics Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. BioFire Diagnostics Molecular Diagnostics for Infectious Diseases Product
Table 139. BioFire Diagnostics Recent Developments/Updates
Table 140. Seegene Company Information
Table 141. Seegene Description and Business Overview
Table 142. Seegene Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Seegene Molecular Diagnostics for Infectious Diseases Product
Table 144. Seegene Recent Developments/Updates
Table 145. QuidelOrtho Company Information
Table 146. QuidelOrtho Description and Business Overview
Table 147. QuidelOrtho Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. QuidelOrtho Molecular Diagnostics for Infectious Diseases Product
Table 149. QuidelOrtho Recent Developments/Updates
Table 150. ZeptoMetrix Company Information
Table 151. ZeptoMetrix Description and Business Overview
Table 152. ZeptoMetrix Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. ZeptoMetrix Molecular Diagnostics for Infectious Diseases Product
Table 154. ZeptoMetrix Recent Developments/Updates
Table 155. Sansure Company Information
Table 156. Sansure Description and Business Overview
Table 157. Sansure Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Sansure Molecular Diagnostics for Infectious Diseases Product
Table 159. Sansure Recent Developments/Updates
Table 160. BGI Genomics Company Information
Table 161. BGI Genomics Description and Business Overview
Table 162. BGI Genomics Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. BGI Genomics Molecular Diagnostics for Infectious Diseases Product
Table 164. BGI Genomics Recent Developments/Updates
Table 165. DaAn Gene Company Information
Table 166. DaAn Gene Description and Business Overview
Table 167. DaAn Gene Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. DaAn Gene Molecular Diagnostics for Infectious Diseases Product
Table 169. DaAn Gene Recent Developments/Updates
Table 170. Kehua Bio-engineering Company Information
Table 171. Kehua Bio-engineering Description and Business Overview
Table 172. Kehua Bio-engineering Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 173. Kehua Bio-engineering Molecular Diagnostics for Infectious Diseases Product
Table 174. Kehua Bio-engineering Recent Developments/Updates
Table 175. Key Raw Materials Lists
Table 176. Raw Materials Key Suppliers Lists
Table 177. Molecular Diagnostics for Infectious Diseases Distributors List
Table 178. Molecular Diagnostics for Infectious Diseases Customers List
Table 179. Molecular Diagnostics for Infectious Diseases Market Trends
Table 180. Molecular Diagnostics for Infectious Diseases Market Drivers
Table 181. Molecular Diagnostics for Infectious Diseases Market Challenges
Table 182. Molecular Diagnostics for Infectious Diseases Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
Table 186. Authors List of This Report
List of Figures
Figure 1. Product Picture of Molecular Diagnostics for Infectious Diseases
Figure 2. Global Molecular Diagnostics for Infectious Diseases Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Molecular Diagnostics for Infectious Diseases Market Share by Type: 2024 & 2031
Figure 4. Respiratory Tract Infections Product Picture
Figure 5. Reproductive Tract Infections Product Picture
Figure 6. Blood-borne Infections (BBIs) Product Picture
Figure 7. Gastrointestinal Infections (GIIs) Product Picture
Figure 8. Other Infections Product Picture
Figure 9. Global Molecular Diagnostics for Infectious Diseases Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Molecular Diagnostics for Infectious Diseases Market Share by Application: 2024 & 2031
Figure 11. Hospital
Figure 12. Diagnostic Laboratories
Figure 13. Global Molecular Diagnostics for Infectious Diseases Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Molecular Diagnostics for Infectious Diseases Market Size (2020-2031) & (US$ Million)
Figure 15. Global Molecular Diagnostics for Infectious Diseases Sales (2020-2031) & (K Units)
Figure 16. Global Molecular Diagnostics for Infectious Diseases Average Price (US$/Unit) & (2020-2031)
Figure 17. Molecular Diagnostics for Infectious Diseases Report Years Considered
Figure 18. Molecular Diagnostics for Infectious Diseases Sales Share by Manufacturers in 2024
Figure 19. Global Molecular Diagnostics for Infectious Diseases Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Molecular Diagnostics for Infectious Diseases Players: Market Share by Revenue in Molecular Diagnostics for Infectious Diseases in 2024
Figure 21. Molecular Diagnostics for Infectious Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Molecular Diagnostics for Infectious Diseases Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Molecular Diagnostics for Infectious Diseases Sales Market Share by Country (2020-2031)
Figure 24. North America Molecular Diagnostics for Infectious Diseases Revenue Market Share by Country (2020-2031)
Figure 25. United States Molecular Diagnostics for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Molecular Diagnostics for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Molecular Diagnostics for Infectious Diseases Sales Market Share by Country (2020-2031)
Figure 28. Europe Molecular Diagnostics for Infectious Diseases Revenue Market Share by Country (2020-2031)
Figure 29. Germany Molecular Diagnostics for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Molecular Diagnostics for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Molecular Diagnostics for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Molecular Diagnostics for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Molecular Diagnostics for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Molecular Diagnostics for Infectious Diseases Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Molecular Diagnostics for Infectious Diseases Revenue Market Share by Region (2020-2031)
Figure 36. China Molecular Diagnostics for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Molecular Diagnostics for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Molecular Diagnostics for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Molecular Diagnostics for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Molecular Diagnostics for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Molecular Diagnostics for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Molecular Diagnostics for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Molecular Diagnostics for Infectious Diseases Sales Market Share by Country (2020-2031)
Figure 44. Latin America Molecular Diagnostics for Infectious Diseases Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Molecular Diagnostics for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Molecular Diagnostics for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Molecular Diagnostics for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Molecular Diagnostics for Infectious Diseases Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Molecular Diagnostics for Infectious Diseases Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Molecular Diagnostics for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Molecular Diagnostics for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Molecular Diagnostics for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Molecular Diagnostics for Infectious Diseases by Type (2020-2031)
Figure 54. Global Revenue Market Share of Molecular Diagnostics for Infectious Diseases by Type (2020-2031)
Figure 55. Global Molecular Diagnostics for Infectious Diseases Price (US$/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Molecular Diagnostics for Infectious Diseases by Application (2020-2031)
Figure 57. Global Revenue Market Share of Molecular Diagnostics for Infectious Diseases by Application (2020-2031)
Figure 58. Global Molecular Diagnostics for Infectious Diseases Price (US$/Unit) by Application (2020-2031)
Figure 59. Molecular Diagnostics for Infectious Diseases Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global LED Light Housing Market Research Report 2025
Sep 24, 25
Global Side Emitting LED Strip Light Market Research Report 2025
Sep 24, 25
Global Medium and Low Voltage Unshielded Cable Market Research Report 2025
Sep 24, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232